BofA downgrades Universal Health to Underperform on legislation headwinds

BofA downgraded Universal Health (UHS) to Underperform from Neutral with a price target of $185, down from $215. The firm downgraded four healthcare facility and managed care stocks that it believes are most exposed to the One Big Beautiful Bill. The bill has a board range of negative implications and creates downside risk to growth estimates for the sector, the analyst tells investors in a research note. The subsidy cuts to Medicaid and Affordable Care Act exchanges are not reflected in consensus estimates and for many companies not reflected in stock prices, contends BofA.